Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11421183 | 0.90 | LMNA (0.31) | LMNAPKMSMN1; SMN2 | |
| SCHEMBL9501689 | 0.87 | — | — | |
| SCHEMBL196668 | 0.84 | TSHR (0.31) | TSHR | |
| SCHEMBL11765536 | 0.80 | SLC29A1 (0.30) | — | |
| SCHEMBL4630604 | 0.80 | — | — | |
| SCHEMBL16423547 | 0.79 | LMNA (0.33) | LMNAPKMSMN1; SMN2 | |
| SCHEMBL8411784 | 0.78 | MEN1 (0.31) | — | |
| SCHEMBL9501702 | 0.78 | — | — | |
| SCHEMBL8934295 | 0.77 | LMNA (0.37) | ADRB2ADRB1ADRB3LMNAPKM | |
| SCHEMBL18843568 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2154162-B1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION AND CURED MATERIAL | SHOWA DENKO KK (JP) | 2019-07-17 | — | — | EP | disclosed |
| US-8399569-B2 | Reactive urethane compound having ether bond, curable composition, and cured material | SHOWA DENKO K.K. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-1866357-B1 | (METH)ACRYLOYL GROUP-CONTAINING AROMATIC ISOCYANATE COMPOUND AND PRODUCTION PROCESS THEREOF | SHOWA DENKO KK (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-8044235-B2 | (Meth) acryloyl group-containing aromatic isocyanate compound and production process thereof | SHOWA DENKO K.K. (JP) | 2011-10-25 | — | — | US | disclosed |
| EP-1812381-B1 | ETHYLENICALLY UNSATURATED GROUP-CONTAINING ISOCYANATE COMPOUND AND PROCESS FOR PRODUCING THE SAME, AND REACTIVE MONOMER, REACTIVE (METH)ACRYLATE POLYMER AND ITS USE | SHOWA DENKO KK (JP) | 2011-02-16 | — | — | EP | disclosed |
| US-7790354-B2 | Photosensitive resin composition, cured product thereof and production method of printed circuit board using the same | SHOWA DENKO K.K. (JP) | 2010-09-07 | — | — | US | disclosed |
| US-20100160557-A1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION, AND CURED MATERIAL | SHOWA DENKO K.K. (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-2154162-A1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION AND CURED PRODUCT | Showa Denko K.K. (JP) | 2010-02-17 | — | — | EP | disclosed |
| US-7579066-B2 | Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth) acrylate polymer and its use | SHOWA DENKO K.K. (JP) | 2009-08-25 | — | — | US | disclosed |
| US-20090054543-A1 | (Meth) Acryloyl Group-Containing Aromatic Isocyanate Compound and Production Process Thereof | SHOWA DENKO K.K. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-5677398-A | CURABLE EPOXY RESIN, EPOXY COMPOUND OR ADDUCT COMPRISING A TETRAMETHYLSPIROBIINDENE-DIOL; RESISTANT OF SOLDERING, HEAT, MOISTURE, CORROSION, ACID, ALKALI, CHEMICAL; INKS FOR PRINTED-WIRING BOARD | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-10-14 | — | — | US | disclosed |
| EP-0584613-B1 | Thermoplastic moulding matter for manufacture of inorganic sintered bodies as well as process for manufacture of inorganic sintered bodies | BAYER AG (DE) | 1996-10-16 | — | — | EP | disclosed |
| EP-0737701-A2 | Epoxy acrylate resins and their uses | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-10-16 | — | — | EP | disclosed |
| US-5538821-A | SOLDER RESIST, RESIST FOR ELECTROLESS DEPOSITION OF GOLD, EPOXY NOVALAK RESIN REACTED WITH HYDROXYL COMPOUND AND POLYBASIC UNSATURATED CARBOXYLIC ACID | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1996-07-23 | — | — | US | disclosed |
| US-5439964-A | Thermoplastic molding compounds for the production of inorganic sintered moldings and a process for the production of inorganic sintered moldings | BAYER AKTIENGESELLSCHAFT (DE) | 1995-08-08 | — | — | US | disclosed |
| EP-0624824-A1 | Resist ink composition and cured article prepared therefrom | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1994-11-17 | — | — | EP | disclosed |
| US-5310813-A | Copolymer includes alkyl (meth)acrylate and macromolecular monomers; high solids, low viscosity; automobiles, appliances | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1994-05-10 | — | — | US | disclosed |
| EP-0584613-A1 | Thermoplastic moulding matter for manufacture of inorganic sintered bodies as well as process for manufacture of inorganic sintered bodies | BAYER AG (DE) | 1994-03-02 | — | — | EP | disclosed |
| US-5283213-A | Moulding compounds for the production of inorganic sintered mouldings and a process for the production of inorganic sintered mouldings | BAYER AKTIENGESELLSCHAFT (DE) | 1994-02-01 | — | — | US | disclosed |
| EP-0531819-A1 | Moulding composition for the production of inorganic sintered articles and process for the preparation of such articles | BAYER AG (DE) | 1993-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054543-A1 | (Meth) Acryloyl Group-Containing Aromatic Isocyanate Compound and Production Process Thereof | PRMT5, ACR, PRMT1 | ADRB2 2524/4885ADRB1 1590/4885ADRB3 2446/4885 |
| US-20100160557-A1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION, AND CURED MATERIAL | UNC119, MLLT1, H1-0 | ADRB2 2276/4885ADRB1 2347/4885ADRB3 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.